This inventor holds 8 USPTO granted patents and 4 published patent applications. Top assignee: Optimvia, LLC. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Tarsis Gesteira Ferreira: Innovator in Engineered Enzymes
Introduction
Tarsis Gesteira Ferreira is a prominent inventor based in Pearland, TX (US). He has made significant contributions to the field of biochemistry, particularly in the development of engineered enzymes. With a total of 8 patents to his name, Ferreira's work is paving the way for advancements in various applications, including anticoagulant therapies.
Latest Patents
Ferreira's latest patents focus on engineered aryl sulfate-dependent enzymes. These inventions provide several non-naturally occurring sulfotransferase enzymes that have been engineered to react with aryl sulfate compounds as sulfo group donors. Instead of the natural substrate 3'-phosphoadenosine 5'-phosphosulfate (PAPS), these enzymes utilize heparosan-based polysaccharides, particularly heparan sulfate, as sulfo group acceptors. Each engineered sulfotransferase enzyme exhibits biological activity characterized by the position within the heparosan-based polysaccharide that receives the sulfo group. This includes glucosaminyl N-sulfotransferase activity, hexuronyl 2-O sulfotransferase activity, glucosaminyl 6-O sulfotransferase activity, and glucosaminyl 3-O sulfotransferase activity. Additionally, methods for using these engineered sulfotransferases to produce sulfated heparosan-based polysaccharides, including those with anticoagulant activity, are also provided.
Career Highlights
Ferreira has established himself as a key figure in his field through his innovative research and development efforts. His work has not only contributed to scientific knowledge but has also opened new avenues for therapeutic applications.
Collaborations
One of Ferreira's notable collaborators is Daniel H. Lajiness. Their partnership has likely fostered a productive environment for innovation and research.
Conclusion
Tarsis Gesteira Ferreira is a distinguished inventor whose work in engineered enzymes is making a significant impact in biochemistry. His patents reflect a commitment to advancing scientific understanding and practical applications in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile